Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 568 (ZNF568) is a member of the large zinc finger protein family, functioning primarily as a transcriptional repressor[3][4]. It contains two N-terminal KRAB (Krüppel-associated box) domains and an array of 11 C2H2 zinc fingers; this structure enables it to bind DNA and repress specific gene promoters, notably acting as a repressor of the placental-specific Igf2-P0 transcript in the mouse[1]. ZNF568 modulates gene expression in early embryonic development, particularly in extraembryonic tissue morphogenesis and convergent extension movements during gastrulation[1]. It establishes transcriptional silencing through recruitment of epigenetic modifiers such as histone methyltransferases, facilitating H3K9 methylation. The human ortholog appears to be evolutionarily conserved but may have species-specific diversifications in function[1][3]. There is currently no strong evidence that ZNF568 is a direct therapeutic target or interacts with drugs, nor has it been directly implicated as a biomarker or noted for clinical safety concerns in the literature to date[3][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 568 (ZNF568).